Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.38 USD | -3.26% | -13.93% | -29.88% |
09/05 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
09/05 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
206.26Cr | - | |||||
5.46TCr | - | |||||
3.99TCr | ||||||
3.88TCr | ||||||
2.69TCr | ||||||
2.62TCr |